This inventor holds 1 USPTO granted patent and 7 published patent applications. Top assignee: Novartis Ag. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Nichola Smith: Innovator in NLRP3 Inflammasome Inhibitors
Introduction
Nichola Smith is a prominent inventor based in Burlington, MA (US). He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of novel compounds that target the NLRP3 inflammasome.
Latest Patents
Nichola holds 1 patent related to NLRP3 inflammasome inhibitors. His patent describes novel pyridazin-3-yl phenol compounds that inhibit NOD-like receptor protein 3 (NLRP3) inflammasome activity. The invention also encompasses the processes for preparing these compounds, pharmaceutical compositions, and their use in treating diseases and disorders mediated by NLRP3.
Career Highlights
Nichola is currently associated with Novartis AG, a leading global healthcare company. His work focuses on innovative solutions that address critical health challenges through advanced pharmaceutical research.
Collaborations
Nichola collaborates with talented professionals in his field, including Christopher Farady and Nina Gommermann, who contribute to the advancement of their shared research goals.
Conclusion
Nichola Smith's work in developing NLRP3 inflammasome inhibitors showcases his commitment to innovation in the pharmaceutical industry. His contributions are paving the way for new treatments that could significantly impact patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile